(Q37933448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21923668%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Target levels of functional C1-inhibitor in hereditary angioedema (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21923668%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21923668%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Marco Cicardi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21923668%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

C E Hack

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21923668%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

E S van Amersfoort

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21923668%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

19 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21923668%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21923668%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21923668%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21923668%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

123-130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21923668%20AND%20SRC:MED&resulttype=core&format=json

Hereditary angio-oedema in Denmark: a nationwide survey

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Clinical practice. Hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Bradykinin-mediated angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Plasma bradykinin in angio-oedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Recombinant human C1-inhibitor in the treatment of acute angioedema attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Production of a complement inhibitor possessing sialyl Lewis X moieties by in vitro glycosylation technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Recombinant C1 inhibitor in brain ischemic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X

Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02716.X